Net profit of Ipca Laboratories rose 23.13% to Rs 282.57 crore in the quarter ended September 2025 as against Rs 229.48 crore during the previous quarter ended September 2024. Sales rose 8.56% to Rs 2556.50 crore in the quarter ended September 2025 as against Rs 2354.90 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 2556.50 | 2354.90 | 9 |
| OPM % | 21.32 | 18.75 | - |
| PBDT | 553.17 | 445.18 | 24 |
| PBT | 449.84 | 344.83 | 30 |
| NP | 282.57 | 229.48 | 23 |